Genzyme, Synaptics may see evening-session action

Shares of Genzyme Corp. may see further action late Friday following a tough ride during the day after federal drug regulators told the company that it wants to conduct another inspection of one of its plants.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.